AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 51-75/186
Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation
Authors: Hasdai, D Harrington, RA Hochman, JS Califf, RM Battler, A Box, JW Simoons, ML Deckers, J Topol, EJ Holmes, DR
Citation: D. Hasdai et al., Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation, J AM COL C, 36(3), 2000, pp. 685-692
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease - One-year results of the ESSENCE study
Authors: Goodman, SG Cohen, M Bigonzi, F Gurfinkel, EP Radley, DR Le Iouer, V Fromell, GJ Demers, C Turpie, AGG Califf, RM Fox, KAA Langer, A
Citation: Sg. Goodman et al., Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease - One-year results of the ESSENCE study, J AM COL C, 36(3), 2000, pp. 693-698
ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction
Authors: Braunwald, E Antman, EM Beasley, JW Califf, RM Cheitlin, MD Hochman, JS Jones, RH Kereiakes, D Kupersmith, J Levin, TN Pepine, CJ Schaeffer, JW Smith, EE Steward, DE Theroux, P Gibbons, RJ Alpert, JS Eagle, KA Faxon, DP Fuster, V Gardner, TJ Gregoratos, G Russell, RO Smith, SC
Citation: E. Braunwald et al., ACC/AHA guidelines for the management of patients with unstable angina andnon-ST-segment elevation myocardial infarction, J AM COL C, 36(3), 2000, pp. 970-1056
Diabetes mellitus and outcome after primary coronary angioplasty for acutemyocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy (vol 35, pg 1502, 2000)
Authors: Hasdai, D Granger, CB Srivatsa, SS Criger, DA Ellis, SG Califf, RM Topol, EJ Holmes, DR
Citation: D. Hasdai et al., Diabetes mellitus and outcome after primary coronary angioplasty for acutemyocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy (vol 35, pg 1502, 2000), J AM COL C, 36(2), 2000, pp. 660-660
Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy
Authors: Sane, DC Damaraju, LV Topol, EJ Cabot, CF Mascelli, MA Harrington, RA Simoons, ML Califf, RM
Citation: Dc. Sane et al., Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy, J AM COL C, 36(1), 2000, pp. 75-83
Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000
Authors: Kleiman, NS Califf, RM
Citation: Ns. Kleiman et Rm. Califf, Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000, J AM COL C, 36(1), 2000, pp. 310-310
Diabetes mellitus and outcome after primary coronary angioplasty for acutemyocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy
Authors: Hasdai, D Granger, CB Srivatsa, SS Criger, DA Ellis, SG Califf, RM Topol, EJ Holmes, DR
Citation: D. Hasdai et al., Diabetes mellitus and outcome after primary coronary angioplasty for acutemyocardial infarction: Lessons from the GUSTO-IIb angioplasty substudy, J AM COL C, 35(6), 2000, pp. 1502-1512
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
Authors: Lincoff, AM Califf, RM Topol, EJ
Citation: Am. Lincoff et al., Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease, J AM COL C, 35(5), 2000, pp. 1103-1115
Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status
Authors: Alderman, EL Brooks, MM Bourassa, M Califf, RM Chaitman, BR Detre, K Faxon, D Frye, R Hardison, RM Hlatky, M Holubkov, R Jones, RH Kelsey, SF Schaff, H Shemin, RJ Sopko, G Sutton-Tyrrell, K Williams, DO
Citation: El. Alderman et al., Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status, J AM COL C, 35(5), 2000, pp. 1122-1129
Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis - Reexamining the "gold standard" for myocardial reperfusion assessment
Authors: Shah, A Wagner, GS Granger, CB O'Connor, CM Green, CL Trollinger, KM Califf, RM Krucoff, MW
Citation: A. Shah et al., Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis - Reexamining the "gold standard" for myocardial reperfusion assessment, J AM COL C, 35(3), 2000, pp. 666-672
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction
Authors: Hasdai, D Califf, RM Thompson, TD Hochman, JS Ohman, EM Pfisterer, M Bates, ER Vahanian, A Armstrong, PW Criger, DA Topol, EJ Holmes, DR
Citation: D. Hasdai et al., Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction, J AM COL C, 35(1), 2000, pp. 136-143
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes - Results from PURSUIT
Authors: Akkerhuis, KM Deckers, JW Boersma, E Harrington, RA Stepinska, J Mahaffey, KW Wilcox, RG Lincoff, AM Keltai, M Topol, EJ Califf, RM Simoons, ML
Citation: Km. Akkerhuis et al., Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes - Results from PURSUIT, EUR HEART J, 21(5), 2000, pp. 371-381
Lack of progress in cardiogenic shock: lessons from the GUSTO trials
Authors: Menon, V Hochman, JS Stebbins, A Pfisterer, M Col, J Anderson, RD Hasdai, D Holmes, DR Bates, ER Topol, EJ Califf, RM Ohman, EM
Citation: V. Menon et al., Lack of progress in cardiogenic shock: lessons from the GUSTO trials, EUR HEART J, 21(23), 2000, pp. 1928-1936
Influence of diabetes mellitus on clinical outcomes across the spectrum ofacute coronary syndromes - Findings from the GUSTO-IIb Study
Authors: McGuire, DK Emanuelsson, H Granger, CB Ohman, EM Moliterno, DJ White, HD Ardissino, D Box, JW Califf, RM Topol, EJ
Citation: Dk. Mcguire et al., Influence of diabetes mellitus on clinical outcomes across the spectrum ofacute coronary syndromes - Findings from the GUSTO-IIb Study, EUR HEART J, 21(21), 2000, pp. 1750-1758
Inter-regional differences in acute coronary syndrome trials
Authors: O'Shea, JC Califf, RM
Citation: Jc. O'Shea et Rm. Califf, Inter-regional differences in acute coronary syndrome trials, EUR HEART J, 21(17), 2000, pp. 1397-1399
National and regional registries: what good are they?
Authors: Dyke, CK Califf, RM
Citation: Ck. Dyke et Rm. Califf, National and regional registries: what good are they?, EUR HEART J, 21(17), 2000, pp. 1401-1403
Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial
Authors: Tcheng, JE O'Shea, JC Cohen, EA Pacchiana, CM Kitt, MM Lorenz, TJ Greenberg, S Strony, J Califf, RM Buller, C Cantor, WJ Joseph, DM Kitt, MM Lincoff, AM Madan, M Popma, J Teirstein, P Cohen, E Balleza, L Parsons, P Lui, H Young, J Fox, R Labinaz, M Jelley, J Williams, J Cohen, D Trovato, M Smith, J Henry, P Chisholm, R O'Donnell, D Talley, JD Pacheco, R Timmis, S Muraka, A Mann, T Cubeddu, G Tannenbaum, M Greene, J Santoian, E Wash, M Sheldon, S Pronesti, L Jain, A Alonzo, M Seidelin, P Richards, J Lopez, M Dittenber, R Johnson, K Levine, G Maresh, K Ferrando, T Sarembock, I Snyder, L Kieval, J Herlan, L Miller, M Bembridge, D Nair, R Hickel, L Kiernan, F Murphy, D Cloutier, J Conn, E Beardsley, J Ritchie, M Cragen, D Jafar, MZ Counihan, P Rosenfelder, D Ducas, J Montebruno, L Carere, R Radons, B Williams, L Owens, W Dougal, R Feldman, R Audrain, D Karamali, A Smith, M Blankenship, J Demko, SL Thompson, M Gacoich, G Chiodo, V Noll, P Ledley, G Miller, C Felten, W Garner, B Chandler, AB Easler, P Albin, G Page, A Maddox, W Allen, S Gilchrist, I Moore, R Zimmerman, H Curtis, M Hildebrand, K Greene, R Healy, E Meengs, W Carson, D George, J Roncevich, T Aharonian, V Browning, R Kostuk, W Carr, S Feit, F Gostomsky, B Butman, S Hannah, E Hassel, CD Hartley, D Shook, T Hiller-Mullin, S Brill, D Dillion, M Armstrong, B Kerns, D Pichard, A Okubagzi, P Nasser, T Driver, L Garrett, J Boltey, L Stouffer, G Potter, M Amidon, T Eggert, S Taussig, A Potter, K Natarajan, M Tartaglia, C Werner, J Dunlap, T Harrold-Runge, P Davidson, C Goodreau, L Herzog, W Calamunci, N Slater, A Tormey, D Phillips, W White, D Sridhar, K White, J Goodman, D Buchbinder, M Nasser, V Rapeport, K Vorman, P Weiner, B Borbone, M Shadoff, N Paap, C Rehman, A Haag, E Burchenal, J Kioussopoulos, K Senior, D Senior, J Piana, R Kirshenbaum, J Chan, S Chowdry, A Kraft, P Clark, V Fox, M Deutsch, E Shannon, T Quesada, R Brotherton, J Murrin, C Cinderella, J Hearne, S Seefried, V Farah, T Pakstis, D Bartolet, B Bond, C Debarardinis, C Montory, D Smith, G Gray, D Phillips, P Hathaway, S Manoukian, S Patrick, C Yakubov, S Brooks, J Block, P Block, B Muhlestein, JB Kim, S Shalev, Y Schmidt, W Resar, J Citro, K Stine, R Zumbuhl, J Moreyra, A Kreiger, S Berger, P Cannon, CP Fisher, L Hasselblad, V Foster, A Joseph, D Madan, M McLendon, C Rund, M Tillery, N Wood, F Mahaffey, KW Irwin, C Kulick, D Johnson, N Chen, J Greenberg, S Hogeboom, C Lorenz, TJ Terifay, R Strony, J Veltri, E
Citation: Je. Tcheng et al., Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial, LANCET, 356(9247), 2000, pp. 2037-2044
Randomisation in the SYMPHONY trial - Reply
Authors: Newby, LK Bhapkar, MV Lee, KL Califf, RM
Citation: Lk. Newby et al., Randomisation in the SYMPHONY trial - Reply, LANCET, 356(9240), 2000, pp. 1521-1522
Cardiogenic shock complicating acute coronary syndromes
Authors: Hasdai, D Topol, EJ Califf, RM Berger, PB Holmes, DR
Citation: D. Hasdai et al., Cardiogenic shock complicating acute coronary syndromes, LANCET, 356(9231), 2000, pp. 749-756
All that glitters is not gold
Authors: Velazquez, EJ Califf, RM
Citation: Ej. Velazquez et Rm. Califf, All that glitters is not gold, LANCET, 355(9215), 2000, pp. 1568-1569
Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial
Authors: Topol, CE Califf, RM Simes, RJ Van de Werf, F Diaz, R Paolasso, E Aylward, PE Keech, A Klein, W Piegas, L Tomov, I Armstrong, PW Widimsky, P Grande, P Halinen, M Vahanian, A Neuhaus, K Dimas, AP Preda, I Kristinsson, A Tzivoni, D Ardissino, D White, HD Madsen, S Sugrue, D Sadowski, Z Seabra-Gomes, R Apetrei, E Dalby, A Betriu, A Pfisterer, M Verheugt, F Fox, K Bates, ER Gibler, WB Granger, CB Harrington, RA Hochman, JS Holmes, DR Kleiman, NS Lee, KL Moliterno, DJ Newby, LK Ohman, EM Califf, R Newby, K Zillman, L Lee, K Lemons, P McCourt, B Campbell, C Tardiff, B Snapp, J Bassett, K Hodgson, P Hannan, K Kandzari, L Hawkins, S Hinman-Smith, E McDougal, M Raffetto, K Thompson, D Wehrle, T Ange, C Brown, R Grissom, G Heuckel, M McCall, J Pennachi, W Spychala, M Veasey, S Pullium, M Journey, T Quintero, K Mark, D Davidson-Ray, L Diner, L Nelson, C Sowers, C Webb, G Young, M Bhapkar, M Pacchiana, C Sparapani, R Tuttle, R Weaver, D Borzak, S Douthat, L Topol, E Moliterno, D Konczos, L Baishnab, R Baishnab, R Bakos, A Blashford, L Bratsch, J Brown, K Cadorini, E Carlson, J Clemmons, P DelValle, M Drabik, M Fu, G Gates, K Gibson, Y Heil, L Hill, N Klancar, R McHale, B Montague, E Pasca, N Pergi, L Randall, R Rosso, R Sankovich, K Smith, D Wisniewski, L Witkowski, M Zovkic, V Alexander, K Bhatt, D Brener, S Campbell, L Cho, L Cole, C Deedy, M Foody, J Gassler, J Ghaffari, S Haas, G Kapadia, S Lauer, M Lauer, MS Lincoff, M Lutton, S Marso, S Mukherjee, D Patel, V Penn, M Robbins, M Roe, M Sila, C Thamilarasan, M Wagner, G Armstrong, P Bestilny, S Van de Werf, F Budts, W Graux, S Luyten, A Simes, J Keech, A Kava, M Bower, T Chan, S Crampton, L Monro, C Nayak, M Parente, G Riley, V Wilton, D Aylward, P Dolan, S Thomas, C White, H Scott, M Frye, R Alpert, J Bertrand, M Ryan, T Fisher, L Asarch, L Smith, M Lim, L Bokslag, M Chiu, P Chung, J Collins, S Dougherty, C Guimaraes, D Hakim, Z Mathieson, J Montgomery, L Novotny, B Steiner, B Wittke, B
Citation: Ce. Topol et al., Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial, LANCET, 355(9201), 2000, pp. 337-345
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation
Authors: Alexander, JH Sparapani, RA Mahaffey, KW Deckers, JW Newby, LK Ohman, EM Corbalan, R Chierchia, SL Boland, JB Simoons, ML Califf, RM Topol, EJ Harrington, RA
Citation: Jh. Alexander et al., Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation, J AM MED A, 283(3), 2000, pp. 347-353
beta-blocker therapy for heart failure - The evidence is in, now the work begins
Authors: Califf, RM O'Connor, CM
Citation: Rm. Califf et Cm. O'Connor, beta-blocker therapy for heart failure - The evidence is in, now the work begins, J AM MED A, 283(10), 2000, pp. 1335-1337
Cost effectiveness of early discharge after uncomplicated acute myocardialinfarction.
Authors: Newby, LK Eisenstein, EL Califf, RM Thompson, TD Nelson, CL Peterson, ED Armstrong, PW Van de Werf, F White, HD Topol, EJ Mark, DB
Citation: Lk. Newby et al., Cost effectiveness of early discharge after uncomplicated acute myocardialinfarction., N ENG J MED, 342(11), 2000, pp. 749-755
Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: Relation with death and myocardial infarction
Authors: Akkerhuis, KM Maas, ACP Klootwijk, PAJ Krucoff, MW Meij, S Califf, RM Simoons, ML
Citation: Km. Akkerhuis et al., Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: Relation with death and myocardial infarction, J ELCARDIOL, 33(2), 2000, pp. 127-136
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>